Abstract
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism in which immune cell activation is induced by the cross-linking of CD16 with the Fc region of antibodies that at the same time bind specifically to cell surface antigens. ADCC stimulates the secretion of perforin, granzymes, and cytokines leading to lysis of the malignant cells. Natural killer (NK) cells express the CD16 receptor and can therefore be activated by ADCC to kill tumor cells. To study the cytotoxicity of NK cells against cancer cells, an ADCC-based assay is described: the flow cytometry-based cytotoxicity assay. In this method, the antibody trastuzumab, which binds specifically to HER2-positive malignant cells, is used to trigger ADCC.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yamashita M, Kitano S, Aikawa H, Kuchiba A, Hayashi M, Yamamoto N, Tamura K, Hamada A (2016) A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells. Sci Rep 6:19772. https://doi.org/10.1038/srep19772
Morvan MG, Lanier LL (2016) NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer 16(1):7–19. https://doi.org/10.1038/nrc.2015.5
Abbas A, Lichtman AH, Pillai S (2014) Cellular and molecular immunology. 8th edn. Elsevier
Altfeld M, Fadda L, Frleta D, Bhardwaj N (2011) DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11:176–186
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast Cancer that overexpresses HER2. N Engl J Med 344(11):783–792. https://doi.org/10.1056/nejm200103153441101
Yu L, Wang Y, Yao Y, Li W, Lai Q, Li J, Zhou Y, Kang T, Xie Y, Wu Y, Chen X, Yi C, Gou L, Yang J (2014) Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model. Int J Gynecol Cancer 24(7):1158–1164. https://doi.org/10.1097/igc.0000000000000179
Tak W, Mak MES (2006) MHC: the major histocompatibility complex. The immune response. Elsevier
Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14(2):181–196
Kiessling R, Klein E (1973) Cytotoxic potential of mouse spleen cells on H-2 antibody-treated target cells. J Exp Med 137(2):527–532
Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM (2010) New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines 9(6):601–616. https://doi.org/10.1586/erv.10.49
NK cell isolation kit. Miltenyi Biotec. http://www.miltenyibiotec.com/en/products-and-services/macs-cell-separation/cell-separation-reagents/microbeads-and-isolation-kits/nk-cells/nk-cell-isolation-kit-human.aspx
CellTrace™ CFSE Cell Proliferation Kit, for flow cytometry. ThermoFisher Scientific. https://www.thermofisher.com/order/catalog/product/C34554
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
van der Haar Àvila, I., Marmol, P., Cany, J., Kiessling, R., Pico de Coaña, Y. (2019). Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry. In: Pico de Coaña, Y. (eds) Immune Checkpoint Blockade. Methods in Molecular Biology, vol 1913. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8979-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8979-9_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8978-2
Online ISBN: 978-1-4939-8979-9
eBook Packages: Springer Protocols